In case of the BMS-COPD sub-group, decreased serum SCGB1A1 levels have been also detected with higher GOLD stages, mMRC grade, CAT score, BODE index, and SGRQ-C (%). Here, SCGB1A1 is linked to chronic obstructive pulmonary disease.